BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Somatic Cell Gene Editing - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Somatic Cell Gene Editing
X-ORIGINAL-URL:https://scge.mcw.edu
X-WR-CALDESC:Events for Somatic Cell Gene Editing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241030
DTEND;VALUE=DATE:20241102
DTSTAMP:20260417T062933
CREATED:20240808T144734Z
LAST-MODIFIED:20240808T144734Z
UID:4362-1730246400-1730505599@scge.mcw.edu
SUMMARY:6th Annual Gene Therapy Analytical Development & CMC Summit
DESCRIPTION:The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development\, CMC\, QC\, and process development experts to showcase innovative analytical and process development methods\, assess their readiness\, and ultimately guarantee safety\, quality\, efficacy\, and consistency of gene therapies to regulators. \n\nBoston\, MA \nLearn more at https://www.genetherapy-analytical-cmc.com/
URL:https://scge.mcw.edu/events/6th-annual-gene-therapy-analytical-development-cmc-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-094701.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241119
DTEND;VALUE=DATE:20241121
DTSTAMP:20260417T062933
CREATED:20240820T162523Z
LAST-MODIFIED:20240820T162523Z
UID:4439-1731974400-1732147199@scge.mcw.edu
SUMMARY:Breakthroughs in Muscular Dystrophy
DESCRIPTION:Join ASGCT and the Muscular Dystrophy Association in downtown Chicago for an unparalleled opportunity to delve into the latest advancements in research on gene and cell therapies for muscular dystrophy. This 1.5-day event will bring together leading researchers and clinicians from the neuromuscular disease community to explore cutting-edge gene and cell therapies and technologies for muscular dystrophy. \nChicago\, IL \nhttps://www.asgct.org/events/breakthroughs-in-muscular-dystrophy/registration
URL:https://scge.mcw.edu/events/breakthroughs-in-muscular-dystrophy/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-20-112456.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20241120T080000
DTEND;TZID=America/Chicago:20241120T150000
DTSTAMP:20260417T062933
CREATED:20241029T213601Z
LAST-MODIFIED:20241029T213601Z
UID:4634-1732089600-1732114800@scge.mcw.edu
SUMMARY:FDA Scientific Exchange 2024: Advancing Gene Editing Platforms for Rare Diseases
DESCRIPTION:On November 20th\, ISCT\, ARM\, and Danaher will convene key stakeholders to explore how to advance gene editing platforms. This Scientific Exchange with the FDA seeks to make progress on therapeutic development for rare conditions that are scientifically feasible but commercially non-viable. The Exchange will review case studies from academics and industry developers focused on gene editing\, with the objective of defining repeatable platforms that streamline development and regulatory requirements across multiple therapies for rare populations. Successful platforms hold promise to deliver faster and broader patient access to novel gene therapies while maintaining favorable risk-benefit balance and appropriate regulatory rigor. The attached background materials provide additional context. \nThe event will be live-streamed. \nRegister at https://www.isctglobal.org/event/fda-scientific-exchange-2024
URL:https://scge.mcw.edu/events/fda-scientific-exchange-2024-advancing-gene-editing-platforms-for-rare-diseases/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-29-163510.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20241122T120000
DTEND;TZID=America/Chicago:20241122T124500
DTSTAMP:20260417T062933
CREATED:20241022T150033Z
LAST-MODIFIED:20241022T150033Z
UID:4597-1732276800-1732279500@scge.mcw.edu
SUMMARY:Real-World Evidence Webinar Series: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
DESCRIPTION:The Reagan-Udall Foundation for the FDA\, in collaboration with the Food and Drug Administration (FDA)\, is hosting a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE). This latest session in the webinar series will discuss the draft guidance: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice. \nThe guidance document addresses randomized controlled trials (RCTs) that have been integrated within routine clinical practice. Such RCTs have streamlined protocols that focus on collection of essential data and are often referred to as point-of-care or large\, simple trials. The guidance document discusses how leveraging established health care institutions can help reduce startup time and support trial enrollment. Involving local health care providers also offers convenience and accessibility to diverse patient populations who may not otherwise have the opportunity to participate. \nRegister at https://reaganudall.org/news-and-events/events/real-world-evidence-webinar-series-integrating-randomized-controlled-trials
URL:https://scge.mcw.edu/events/real-world-evidence-webinar-series-integrating-randomized-controlled-trials-for-drug-and-biological-products-into-routine-clinical-practice/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-22-095942.png
END:VEVENT
END:VCALENDAR